DNA Repair Genes: Safeguards of Genomic Integrity
DNA repair genes preserve cellular stability by correcting damage sustained during physiological DNA replication or induced by environmental insults (such as UV radiation, ionizing radiation, and chemical mutagens). From a high-yield board perspective, these genes act as specialized caretaker tumor suppressors. Inherited loss-of-function mutations in these repair pathways compromise the genome’s fidelity, leading to a hypermutable state and highly characteristic cancer predisposition syndromes.
1. Foundational DNA Repair Pathways
Different types of structural DNA lesions require distinct biochemical machinery for targeted excision or rejoining:
| Repair Mechanism | Biochemical Steps & Core Enzymes | Targeted Lesion Type |
|---|---|---|
| Nucleotide Excision Repair (NER) | Specific endonucleases recognize bulky helical distortions, cleaving and removing an oligonucleotide fragment (~12-24 bases). DNA polymerase fills the gap, and DNA ligase seals it. Occurs primarily in the G1 phase. | Bulky, helix-distorting lesions, classically **UV-induced pyrimidine dimers** (thymine dimers). |
| Mismatch Repair (MMR) | MutS homologs recognize mismatched bases or small insertion/deletion loops in newly synthesized strands. The erroneous segment is excised, and the template strand is used to rewrite the sequence. Occurs during the S phase. | Mismatched, non-complementary single bases (e.g., G-T pairing) are missed by DNA polymerase proofreading. |
| Base Excision Repair (BER) | 1. Specific **DNA glycosylases** remove the altered base, creating an AP (apurinic/apyrimidinic) site. 2. **AP-endonuclease** cleaves the 5′ end, and **AP-lyase** clears the 3′ sugar residue. 3. DNA polymerase-beta inserts the correct nucleotide, and DNA ligase III seals it. Throughout the cell cycle. |
Spontaneous or oxidative single-base alterations, such as cytosine deamination (converting cytosine into uracil). |
| Homologous Recombination (HR) | An error-free mechanism that utilizes a homologous intact sister chromatid as a template to accurately synthesize and repair broken strands. Requires functional BRCA1/2 and RAD51. Restricted to S and G2 phases. | Exogenous or replication-fork-induced **double-stranded DNA breaks (DSBs)**. |
| Non-Homologous End Joining (NHEJ) | A rapid, error-prone mechanism that re-ligates two broken ends of DNA directly back together. No template is used; nucleotides are frequently lost or added. Requires Ku proteins and DNA-PK. Available throughout the cell cycle. | Double-stranded DNA breaks are caused by ionizing radiation or oxidative stress. (Also natively used in V(D)J recombination). |
2. High-Yield Genes and Clinical Defect Syndromes
Correlating inherited gene mutations with their disrupted molecular pathway and resulting clinical presentations is essential for diagnostic analysis:
- Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer / HNPCC):
Autosomal dominant mutation in mismatch repair genes, most commonly MSH2 or MLH1 (alongside MSH6 and PMS2). Loss of MMR activity results in **microsatellite instability (MSI)**, characterized by rapid changes in the length of short, repetitive DNA sequences across the genome.• Clinical Presentation: Early-onset colorectal cancer (proximal colon predominance, arising from flat adenomas) and a significantly increased risk for endometrial and ovarian carcinomas.
- Xeroderma Pigmentosum (XP):
Autosomal recessive deficiency in key nucleotide excision repair proteins, often involving the XPA through XPG gene family. Cells completely lose the ability to excise pyrimidine dimers formed by ultraviolet light.• Clinical Presentation: Severe cutaneous photosensitivity upon minimal sun exposure, marked hyperpigmentation, poikiloderma, and a greater than 1000-fold increase in the risk of developing early-onset skin malignancies (basal cell carcinoma, squamous cell carcinoma, and cutaneous melanoma).
- Hereditary Breast and Ovarian Cancer Syndrome:
Autosomal dominant loss-of-function mutations in the BRCA1 or BRCA2 genes crippling the high-fidelity homologous recombination pathway for double-stranded breaks.• Clinical Presentation: High lifetime risk for early, bilateral invasive ductal carcinomas of the breast, serous ovarian carcinoma, and increased susceptibility to pancreatic and prostate malignancies.
- Ataxia-Telangiectasia:
Autosomal recessive mutation in the ATM gene, which encodes a serine/threonine kinase responsible for sensing double-stranded DNA breaks and activating p53-dependent cell cycle checkpoints. Defective ATM causes a combined failure of non-homologous end joining and homologous recombination.• Clinical Presentation: The classic clinical triad of progressive cerebellar ataxia (gait unsteadiness), oculocutaneous telangiectasias (dilated capillaries), and severe IgA deficiency leading to recurrent sinopulmonary infections. Increased risk for lymphomas and leukemias.
- Fanconi Anemia:
Autosomal recessive mutations in the FANC gene cluster (e.g., FANCA, FANCC, FANCG), whose proteins form a nuclear complex responsible for clearing DNA interstrand cross-links.• Clinical Presentation: Progressive bone marrow failure (aplastic anemia developing in the first decade of life), congenital malformations including absent or hypoplastic thumbs and radii, short stature, and cafe-au-lait spots. Marked predisposition to Acute Myeloid Leukemia (AML) and squamous cell carcinomas of the head and neck.